💨 Abstract

Lexicon Pharmaceuticals Inc. (LXRX) reported a second-quarter net income of $3.3 million, or $0.01 per share, which exceeded analysts' expectations of an 8-cent loss. The company’s revenue was $28.9 million, surpassing the projected $6.5 million. This performance outperformed Wall Street forecasts.

Courtesy: WTOP Staff